These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24234649)

  • 1. Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling.
    Kawahara G; Gasperini MJ; Myers JA; Widrick JJ; Eran A; Serafini PR; Alexander MS; Pletcher MT; Morris CA; Kunkel LM
    Hum Mol Genet; 2014 Apr; 23(7):1869-78. PubMed ID: 24234649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
    Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
    J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.
    Adamo CM; Dai DF; Percival JM; Minami E; Willis MS; Patrucco E; Froehner SC; Beavo JA
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19079-83. PubMed ID: 20956307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice.
    Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J
    Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug screening in a zebrafish model of Duchenne muscular dystrophy.
    Kawahara G; Karpf JA; Myers JA; Alexander MS; Guyon JR; Kunkel LM
    Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5331-6. PubMed ID: 21402949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted expression of heme oxygenase-1 in satellite cells improves skeletal muscle pathology in dystrophic mice.
    Florczyk-Soluch U; Polak K; Jelinkova S; Bronisz-Budzyńska I; Sabo R; Bolisetty S; Agarwal A; Werner E; Józkowicz A; Stępniewski J; Szade K; Dulak J
    Skelet Muscle; 2024 Jun; 14(1):13. PubMed ID: 38867250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zebrafish based small molecule screens for novel DMD drugs.
    Kawahara G; Kunkel LM
    Drug Discov Today Technol; 2013; 10(1):e91-6. PubMed ID: 24050235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA.
    Lambert MR; Spinazzola JM; Widrick JJ; Pakula A; Conner JR; Chin JE; Owens JM; Kunkel LM
    Mol Ther; 2021 Mar; 29(3):1086-1101. PubMed ID: 33221436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the therapeutic utility of phosphodiesterase 5A inhibition in the mdx mouse model of duchenne muscular dystrophy.
    Percival JM; Adamo CM; Beavo JA; Froehner SC
    Handb Exp Pharmacol; 2011; (204):323-44. PubMed ID: 21695647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency.
    Khairallah M; Khairallah RJ; Young ME; Allen BG; Gillis MA; Danialou G; Deschepper CF; Petrof BJ; Des Rosiers C
    Proc Natl Acad Sci U S A; 2008 May; 105(19):7028-33. PubMed ID: 18474859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct allostery induced in the cyclic GMP-binding, cyclic GMP-specific phosphodiesterase (PDE5) by cyclic GMP, sildenafil, and metal ions.
    Biswas KH; Visweswariah SS
    J Biol Chem; 2011 Mar; 286(10):8545-8554. PubMed ID: 21193396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
    Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
    FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutraceutical Screening in a Zebrafish Model of Muscular Dystrophy: Gingerol as a Possible Food Aid.
    Licitra R; Marchese M; Brogi L; Fronte B; Pitto L; Santorelli FM
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33808773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment.
    Li M; Andersson-Lendahl M; Sejersen T; Arner A
    FASEB J; 2014 Apr; 28(4):1593-9. PubMed ID: 24371125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure.
    Gong W; Duan Q; Cai Z; Chen C; Ni L; Yan M; Wang X; Cianflone K; Wang DW
    Br J Pharmacol; 2013 Dec; 170(7):1396-409. PubMed ID: 24032459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.
    Waugh TA; Horstick E; Hur J; Jackson SW; Davidson AE; Li X; Dowling JJ
    Hum Mol Genet; 2014 Sep; 23(17):4651-62. PubMed ID: 24760771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation.
    Alexander MS; Kawahara G; Motohashi N; Casar JC; Eisenberg I; Myers JA; Gasperini MJ; Estrella EA; Kho AT; Mitsuhashi S; Shapiro F; Kang PB; Kunkel LM
    Cell Death Differ; 2013 Sep; 20(9):1194-208. PubMed ID: 23764775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperactive adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G modulation.
    Seo K; Rainer PP; Lee DI; Hao S; Bedja D; Birnbaumer L; Cingolani OH; Kass DA
    Circ Res; 2014 Feb; 114(5):823-32. PubMed ID: 24449818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.